Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche names new global head, oncology

This article was originally published in Scrip

Executive Summary

Swiss big pharma Roche has named Dr Dietmar Berger global head of clinical development for oncology and hematology. He succeeds Dr Sandra Homing in the position, who was promoted to chief medical officer at the company in January 2014. Previously Dr Berger was vice-president of global clinical development for HER2 breast cancer medicines at Roche. He has more than 20 years' experience in cancer, including as a former practising oncologist.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC024996

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel